p53 binds the mdmx mRNA and controls its translation

. 2017 Feb 02 ; 36 (5) : 723-730. [epub] 20160704

Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid27375027

MDMX and MDM2 are two nonredundant essential regulators of p53 tumor suppressor activity. MDM2 controls p53 expression levels, whereas MDMX is predominantly a negative regulator of p53 trans-activity. The feedback loops between MDM2 and p53 are well studied and involve both negative and positive regulation on transcriptional, translational and post-translational levels but little is known on the regulatory pathways between p53 and MDMX. Here we show that overexpression of p53 suppresses mdmx mRNA translation in vitro and in cell-based assays. The core domain of p53 binds the 5' untranslated region (UTR) of the mdmx mRNA in a zinc-dependent manner that together with a trans-suppression domain located in p53 N-terminus controls MDMX synthesis. This interaction can be visualized in the nuclear and cytoplasmic compartment. Fusion of the mdmx 5'UTR to the ovalbumin open reading frame leads to suppression of ovalbumin synthesis. Interestingly, the transcription inactive p53 mutant R273H has a different RNA-binding profile compared with the wild-type p53 and differentiates the synthesis of MDMX isoforms. This study describes p53 as a trans-suppressor of the mdmx mRNA and adds a further level to the intricate feedback system that exist between p53 and its key regulatory factors and emphasizes the important role of mRNA translation control in regulating protein expression in the p53 pathway.

Zobrazit více v PubMed

Oncogene. 2001 Mar 29;20(14):1669-77 PubMed

Nature. 1995 Nov 9;378(6553):206-8 PubMed

EMBO J. 1995 Sep 15;14(18):4442-9 PubMed

Nature. 1992 Jul 2;358(6381):80-3 PubMed

PLoS One. 2012;7(8):e42034 PubMed

Cold Spring Harb Perspect Biol. 2010 Feb;2(2):a001107 PubMed

J Biol Chem. 2002 May 31;277(22):19251-4 PubMed

RNA. 2006 Apr;12(4):620-30 PubMed

Nucleic Acids Res. 2005 Aug 09;33(14):4507-18 PubMed

Nat Med. 2012 Aug;18(8):1239-47 PubMed

RNA. 2007 Nov;13(11):1825-33 PubMed

Nat Commun. 2014 Oct 08;5:5067 PubMed

Genes Dev. 1993 Dec;7(12B):2556-64 PubMed

Nat Genet. 2001 Sep;29(1):92-5 PubMed

J Biol Chem. 2000 Feb 25;275(8):5733-8 PubMed

Genes Dev. 2013 Sep 1;27(17 ):1857-67 PubMed

Oncogene. 2001 Aug 2;20(34):4613-20 PubMed

J Biol Chem. 2010 Sep 17;285(38):29111-27 PubMed

Nucleic Acids Res. 2005 Apr 11;33(7):2061-77 PubMed

Cell Cycle. 2009 Jan 1;8(1):31-4 PubMed

Cell Cycle. 2006 Mar;5(5):489-94 PubMed

Mol Cell Biol. 2000 Nov;20(22):8420-31 PubMed

J Biol Chem. 2006 Nov 3;281(44):33036-44 PubMed

Nature. 1995 Nov 9;378(6553):203-6 PubMed

Int J Biochem Cell Biol. 2005 May;37(5):913-9 PubMed

Cancer Cell. 2012 Jan 17;21(1):25-35 PubMed

Mol Cell. 2014 May 8;54(3):500-11 PubMed

Mol Cell. 2006 Jun 23;22(6):741-53 PubMed

Cell Cycle. 2015 ;14 (3):449-58 PubMed

Nat Rev Mol Cell Biol. 2014 Nov;15(11):749-60 PubMed

Oncogene. 2009 Jul 30;28(30):2766-72 PubMed

Cell Cycle. 2015 ;14 (21):3373-8 PubMed

J Biol Chem. 1999 Mar 19;274(12 ):8161-8 PubMed

Nat Rev Mol Cell Biol. 2007 Jun;8(6):479-90 PubMed

Mol Cell Biol. 2004 Jul;24(13):5835-43 PubMed

Nat Cell Biol. 2002 Jun;4(6):462-7 PubMed

Nucleic Acids Res. 2002 Oct 1;30(19):4118-26 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...